Investor directory
Invivo Partners
Invivo Partners aims to become a leading player in Europe's biotech industry by leveraging their team's scientific, technical, and financial expertise.
What they invest in
Geographies
EuropeSpain
The facts
- Typical cheque
- €2M – €10M
- Headquarters
- Barcelona, Spain
- Founded
- 2019
Portfolio
EsoBiotecSanifitMinoryxTelum TherapeuticsCorteria PharmaceuticalsSignadori BioPeptomycNEUmiRNAGyala TherapeuticsArthex BiotechVersantisIntegra TherapeuticsTelomere TherapeuticsOne Chain ImmunotherapeuticsPulmobioticsGlyCardial DiagnosticsMinoryx TherapeuticsSanifit Therapeutics
Does Invivo Partners fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Invivo Partners? Tell us what to correct and we will update it — or ask us to remove the entry.